Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Allergy
Published in: Clinical and Translational Allergy 1/2012

Open Access 01-12-2012 | Research

Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features

Authors: Chrysanthi L Skevaki, Stelios Psarras, Eleni Volonaki, Harris Pratsinis, Irini S Spyridaki, Mina Gaga, Vassiliki Georgiou, Stylianos Vittorakis, Aurica G Telcian, Paraskevi Maggina, Dimitris Kletsas, Dimitrios Gourgiotis, Sebastian L Johnston, Nikolaos G Papadopoulos

Published in: Clinical and Translational Allergy | Issue 1/2012

Login to get access

Abstract

Background

Human rhinoviruses, major precipitants of asthma exacerbations, induce lower airway inflammation and mediate angiogenesis. The purpose of this study was to assess the possibility that rhinoviruses may also contribute to the fibrotic component of airway remodeling.

Methods

Levels of basic fibroblast growth factor (bFGF) mRNA and protein were measured following rhinovirus infection of bronchial epithelial cells. The profibrotic effect of epithelial products was assessed by DNA synthesis and matrix metalloproteinase activity assays. Moreover, epithelial cells were exposed to supernatants from cultured peripheral blood mononuclear cells, obtained from healthy donors or atopic asthmatic subjects and subsequently infected by rhinovirus and bFGF release was estimated. bFGF was also measured in respiratory secretions from atopic asthmatic patients before and during rhinovirus-induced asthma exacerbations.

Results

Rhinovirus epithelial infection stimulated mRNA expression and release of bFGF, the latter being positively correlated with cell death under conditions promoting rhinovirus-induced cytotoxicity. Supernatants from infected cultures induced lung fibroblast proliferation, which was inhibited by anti-bFGF antibody, and demonstrated increased matrix metalloproteinase activity. Rhinovirus-mediated bFGF release was significantly higher in an in vitro simulation of atopic asthmatic environment and, importantly, during rhinovirus-associated asthma exacerbations.

Conclusions

Rhinovirus infection induces bFGF release by airway epithelium, and stimulates stroma cell proliferation contributing to airway remodeling in asthma. Repeated rhinovirus infections may promote asthma persistence, particularly in the context of atopy; prevention of such infections may influence the natural history of asthma.
Appendix
Available only for authorised users
Literature
1.
Holgate ST, Holloway J, Wilson S, Bucchieri F, Puddicombe S, Davies DE: Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc Am Thorac Soc. 2004, 1: 93-98. 10.1513/pats.2306034.CrossRefPubMed
2.
Olman MA: Epithelial cell modulation of airway fibrosis in asthma. Am J Respir Cell Mol Biol. 2003, 28: 125-128. 10.1165/rcmb.F257.CrossRefPubMed
3.
Kumar RK, Herbert C, Foster PS: Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy. 2004, 34: 567-575. 10.1111/j.1365-2222.2004.1917.x.CrossRefPubMed
4.
Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K: Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006, 118: 98-104. 10.1016/j.jaci.2006.02.046.CrossRefPubMed
5.
Xu J, Benyon RC, Leir SH, Zhang S, Holgate ST, Lackie PM: Matrix metalloproteinase-2 from bronchial epithelial cells induces the proliferation of subepithelial fibroblasts. Clin Exp Allergy. 2002, 32: 881-888. 10.1046/j.1365-2745.2002.01386.x.CrossRefPubMed
6.
Bosse Y, Rola-Pleszczynski M: FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends Mol Med. 2008, 14: 3-11. 10.1016/j.molmed.2007.11.003.CrossRefPubMed
7.
Redington AE, Roche WR, Madden J, Frew AJ, Djukanovic R, Holgate ST, Howarth PH: Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol. 2001, 107: 384-387. 10.1067/mai.2001.112268.CrossRefPubMed
8.
Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001, 107: 295-301. 10.1067/mai.2001.111928.CrossRefPubMed
9.
Shute JK, Solic N, Shimizu J, McConnell W, Redington AE, Howarth PH: Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax. 2004, 59: 557-562. 10.1136/thx.2002.002626.PubMedCentralCrossRefPubMed
10.
Zhang S, Smartt H, Holgate ST, Roche WR: Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest. 1999, 79: 395-405.PubMed
11.
Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA: Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995, 310: 1225-1229. 10.1136/bmj.310.6989.1225.PubMedCentralCrossRefPubMed
12.
Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ, Meyer J, Lackie PM, Sanderson G, Holgate ST, Johnston SL: Rhinoviruses infect the lower airways. J Infect Dis. 2000, 181: 1875-1884. 10.1086/315513.CrossRefPubMed
13.
Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, Johnston SL: Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy. 2001, 31: 1060-1066. 10.1046/j.1365-2222.2001.01112.x.CrossRefPubMed
14.
Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST: Airway remodeling in asthma: new insights. J Allergy Clin Immunol. 2003, 111: 215-225. 10.1067/mai.2003.128. quiz 226CrossRefPubMed
15.
Psarras S, Volonaki E, Skevaki CL, Xatzipsalti M, Bossios A, Pratsinis H, Tsigkos S, Gourgiotis D, Constantopoulos AG, Papapetropoulos A: Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol. 2006, 117: 291-297. 10.1016/j.jaci.2005.11.005.CrossRefPubMed
16.
Pratsinis H, Tsagarakis S, Zervolea I, Giannakopoulos F, Stathakos D, Thalassinos N, Kletsas D: Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts. Exp Gerontol. 2002, 37: 1237-1245. 10.1016/S0531-5565(02)00130-4.CrossRefPubMed
17.
Papazafiri P, Kletsas D: Developmental and age-related alterations of calcium homeostasis in human fibroblasts. Exp Gerontol. 2003, 38: 307-311. 10.1016/S0531-5565(02)00201-2.CrossRefPubMed
18.
Xatzipsalti M, Psarros F, Konstantinou G, Gaga M, Gourgiotis D, Saxoni-Papageorgiou P, Papadopoulos NG: Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin Exp Allergy. 2008, 38: 466-472. 10.1111/j.1365-2222.2007.02906.x.CrossRefPubMed
19.
Bossios A, Psarras S, Gourgiotis D, Skevaki CL, Constantopoulos AG, Saxoni-Papageorgiou P, Papadopoulos NG: Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res. 2005, 6: 114-10.1186/1465-9921-6-114.PubMedCentralCrossRefPubMed
20.
Clement MV, Stamenkovic I: Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med. 1994, 180: 557-567. 10.1084/jem.180.2.557.CrossRefPubMed
21.
Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest. 1998, 102: 2041-2049. 10.1172/JCI3480.PubMedCentralCrossRefPubMed
22.
Pratsinis H, Kletsas D, Stathakos D: Autocrine growth regulation in fetal and adult human fibroblasts. Biochem Biophys Res Commun. 1997, 237: 348-353. 10.1006/bbrc.1997.7136.CrossRefPubMed
23.
Beekman B, Drijfhout JW, Bloemhoff W, Ronday HK, Tak PP, te Koppele JM: Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett. 1996, 390: 221-225. 10.1016/0014-5793(96)00665-5.CrossRefPubMed
24.
Tsolia MN, Psarras S, Bossios A, Audi H, Paldanius M, Gourgiotis D, Kallergi K, Kafetzis DA, Constantopoulos A, Papadopoulos NG: Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis. 2004, 39: 681-686. 10.1086/422996.CrossRefPubMed
25.
D'Amore PA: Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev. 1990, 9: 227-238. 10.1007/BF00046362.CrossRefPubMed
26.
Volonaki E, Psarras S, Xepapadaki P, Psomali D, Gourgiotis D, Papadopoulos NG: Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors. Clin Exp Allergy. 2006, 36: 1268-1273. 10.1111/j.1365-2222.2006.02566.x.CrossRefPubMed
27.
Leigh R, Oyelusi W, Wiehler S, Koetzler R, Zaheer RS, Newton R, Proud D: Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol. 2008, 121: 1238-1245. 10.1016/j.jaci.2008.01.067. e1234CrossRefPubMed
28.
Dosanjh A, Rednam S, Martin M: Respiratory syncytial virus augments production of fibroblast growth factor basic in vitro: implications for a possible mechanism of prolonged wheezing after infection. Pediatr Allergy Immunol. 2003, 14: 437-440. 10.1046/j.0905-6157.2003.00090.x.CrossRefPubMed
29.
Mosser AG, Brockman-Schneider R, Amineva S, Burchell L, Sedgwick JB, Busse WW, Gern JE: Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis. 2002, 185: 734-743. 10.1086/339339.CrossRefPubMed
30.
Li D, Zhang C, Song F, Lubenec I, Tian Y, Song QH: VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. Microvasc Res. 2009, 77: 134-142. 10.1016/j.mvr.2008.09.007.CrossRefPubMed
31.
Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS: Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther. 2001, 299: 1073-1085.PubMed
32.
Korpi-Steiner NL, Valkenaar SM, Bates ME, Evans MD, Gern JE, Bertics PJ: Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy. 2010, 40: 1203-1213. 10.1111/j.1365-2222.2010.03546.x.PubMedCentralCrossRefPubMed
33.
Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, Foteinos G, van Drunen CM, Fokkens WJ, D'Ambrosio C: Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy. 2007, 62: 457-470. 10.1111/j.1398-9995.2007.01341.x.CrossRefPubMed
34.
Boero S, Sabatini F, Silvestri M, Petecchia L, Nachira A, Pezzolo A, Scarso L, Rossi GA: Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide. Immunol Lett. 2007, 112: 39-46. 10.1016/j.imlet.2007.06.010.CrossRefPubMed
35.
Hetzel M, Bachem M, Anders D, Trischler G, Faehling M: Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung. 2005, 183: 225-237. 10.1007/s00408-004-2534-z.CrossRefPubMed
36.
Gomez-Pinilla F, Miller S, Choi J, Cotman CW: Heparan sulfate potentiates the autocrine action of basic fibroblast growth factor in astrocytes: an in vivo and in vitro study. Neuroscience. 1997, 76: 137-145.CrossRefPubMed
37.
Bosse Y, Thompson C, Stankova J, Rola-Pleszczynski M: Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 2006, 34: 746-753. 10.1165/rcmb.2005-0309OC.CrossRefPubMed
38.
Tacon CE, Wiehler S, Holden NS, Newton R, Proud D, Leigh R: Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-{kappa}B. Am J Respir Cell Mol Biol. 2010, 43: 201-209. 10.1165/rcmb.2009-0216OC.CrossRefPubMed
39.
Mautino G, Oliver N, Chanez P, Bousquet J, Capony F: Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol. 1997, 17: 583-591.CrossRefPubMed
40.
Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ: Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest. 2002, 122: 1543-1552. 10.1378/chest.122.5.1543.CrossRefPubMed
41.
Belleguic C, Corbel M, Germain N, Lena H, Boichot E, Delaval PH, Lagente V: Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy. 2002, 32: 217-223. 10.1046/j.1365-2222.2002.01219.x.CrossRefPubMed
42.
Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004, 4: 617-629. 10.1038/nri1418.CrossRefPubMed
43.
Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP: Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Biol Chem. 2009, 284: 25854-25866. 10.1074/jbc.M109.033472.PubMedCentralCrossRefPubMed
44.
Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL: A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002, 57: 328-332. 10.1136/thorax.57.4.328.PubMedCentralCrossRefPubMed
45.
Nagarkar DR, Bowman ER, Schneider D, Wang Q, Shim J, Zhao Y, Linn MJ, McHenry CL, Gosangi B, Bentley JK: Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol. 2010, 185: 2525-2535. 10.4049/jimmunol.1000286.PubMedCentralCrossRefPubMed
46.
Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE: Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000, 105: 692-698. 10.1067/mai.2000.104785.CrossRefPubMed
47.
Giri D, Ittmann M: Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol. 2001, 159: 139-147. 10.1016/S0002-9440(10)61681-1.PubMedCentralCrossRefPubMed
48.
Kanazawa H, Yoshikawa T: Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. Chest. 2007, 132: 1169-1174. 10.1378/chest.07-0945.CrossRefPubMed
49.
Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005, 201: 937-947. 10.1084/jem.20041901.PubMedCentralCrossRefPubMed
Metadata
Title
Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features
Authors
Chrysanthi L Skevaki
Stelios Psarras
Eleni Volonaki
Harris Pratsinis
Irini S Spyridaki
Mina Gaga
Vassiliki Georgiou
Stylianos Vittorakis
Aurica G Telcian
Paraskevi Maggina
Dimitris Kletsas
Dimitrios Gourgiotis
Sebastian L Johnston
Nikolaos G Papadopoulos
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2012
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/2045-7022-2-14

Other articles of this Issue 1/2012

Clinical and Translational Allergy 1/2012 Go to the issue

Review

Food allergies in developing and emerging economies: need for comprehensive data on prevalence rates

Research

The 11S globulin Sin a 2 from yellow mustard seeds shows IgE cross-reactivity with homologous counterparts from tree nuts and peanut

Research

Exploring the temporal development of childhood IgE profiles to allergen components

Research

The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms

Research

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time

Position article and guidelines

Research needs in allergy: an EAACI position paper, in collaboration with EFA